Daiichi Sankyo Tightens Oncology Focus Through OTC Divestment To Suntory

$1.6bn Transfer To Complete In 2029

 
• By Lisa Takagi
  
suntory/daiichi
(Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business